Spotlight on Dabigatran Etexilate in the Prevention of Stroke and Systemic Embolism in Patients with Atrial Fibrillation†

Author： Garnock-Jones Karly P.  

Publisher： Adis International

ISSN： 1170-229X

Source： Drugs & Aging, Vol.28, Iss.5, 2011-05, pp. : 415-419

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dabigatran Etexilate: A Review of its Use in the Prevention of Stroke and Systemic Embolism in Patients with Atrial Fibrillation

By Garnock-Jones Karly P.  

American Journal of Cardiovascular Drugs, Vol. 11, Iss. 1, 2011-02 ,pp. : 57-72

Adis International

Access to resources Recommend Favorite

Dabigatran Etexilate: A Pharmacoeconomic Review of its Use in the Prevention of Stroke and Systemic Embolism in Patients with Atrial Fibrillation

By McKeage Kate  

PharmacoEconomics, Vol. 30, Iss. 9, 2012-09 ,pp. : 841-855

Adis International

Access to resources Recommend Favorite

Stop the clots, but at what cost? Pharmacoeconomics of dabigatran etexilate for the prevention of stroke in subjects with atrial fibrillation: a systematic literature review

By Marshall Sarah   Fearon Patricia   Dawson Jesse   Quinn Terence J  

Expert Review of Pharmacoeconomics and Outcomes Research, Vol. 13, Iss. 1, 2013-02 ,pp. : 29-42

Informa Healthcare

Access to resources Recommend Favorite

Dabigatran etexilate: a dab hand for stroke prevention in AF

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 642, 2011-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Guidelines for Stroke Prevention in Patients with Atrial Fibrillation

By Howard P.A.  

Drugs, Vol. 58, Iss. 6, 1999-12 ,pp. : 997-1009

Adis International

Access to resources Recommend Favorite